Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

If you or a loved one were exposed to benzene at work and were diagnosed with cancers such as leukemia, myelodysplasia (MDS), ...

Long-Term Survival Rates of Some Acute Myeloid Leukemia Patients Could Double ... or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of ...

Labcorp LH recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Researchers found that taurine — a common ingredient in energy drinks — may accelerate leukemia progression in mice. While ...

Incyte trades -8.61% away from its average analyst target price of $73.88 per share. The 23 analysts following the stock have set target prices ranging from $52.0 to $96.0, and on average have given ...

An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

The stigma faced by survivors is compounded by the grim reality of childhood cancer survival rates in Kenya. While ...

The cell therapy proved superior to standard-of-care regardless of cytogenetic risk or prior therapy in the CARTITUDE-4 study ...